JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lambertsen, C. J.
Right arrow Articles by Longenhagen, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambertsen, C. J.
Right arrow Articles by Longenhagen, J. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 131, Issue 3, 381-393, 1961
Copyright © 1961 by American Society for Pharmacology and Experimental Therapeutics


THE SEPARATE AND COMBINED RESPIRATORY EFFECTS OF CHLORPROMAZINE AND MEPERIDINE IN NORMAL MEN CONTROLLED AT 46 mm Hg ALVEOLAR pCO2

C. J. Lambertsen 1, H. Wendel 1, and J. B. Longenhagen 1

1 Laboratories of Pharmacology, Schools of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

A method for artificially controlling alveolar pCO2 was used to study the time course of changes in respiratory rate, depth and minute volume after intramuscular administration of physiological saline solution (2 ml), chlorpromazine hydrochloride (25 mg/70 kg), meperidine hydrochloride (100 mg/70 kg) and of meperidine together with chlorpromazine in the stated doses. The method employed provided magnification of drug-induced respiratory alterations by preventing the physiological readjustments in alveolar pCO2 normally associated with changes in alveolar ventilation. The results obtained indicated (a) the time course of a consistent and prominent respiratory depression by meperidine, (b) that chlorpromazine alone produces no consistent respiratory depression but that it may tend to improve tolerance to elevated pCO2, and (c) that administration of chlorpromazine with meperidine causes respiratory depression greater in degree and duration than produced by meperidine alone. The data obtained are discussed with regard to mechanisms of the observed chlorpromazine-meperidine interaction.

Submitted on July 22, 1960







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1961 by the American Society for Pharmacology and Experimental Therapeutics.